Startups building platforms, mechanisms
Regulators open to new endpoints and approval pathways
Investors who understand the long game and the upside
Clinicians & systems who need cost-effective, fertility-sparing solutions
Startups building platforms, mechanisms
Regulators open to new endpoints and approval pathways
Investors who understand the long game and the upside
Clinicians & systems who need cost-effective, fertility-sparing solutions
In endometriosis and adenomyosis, traditional approaches like laparoscopies haven’t kept pace with patient needs. But a new wave of innovators is stepping in—developing therapies that go beyond hormones and surgery. Subscribe: 𝗵𝘁𝘁𝗽𝘀://𝗮𝗿𝘁𝗲𝗺𝗶𝘀.𝗵𝗲𝗮𝗹𝘁𝗵/𝗰𝗼𝗻𝘁𝗮𝗰𝘁
In endometriosis and adenomyosis, traditional approaches like laparoscopies haven’t kept pace with patient needs. But a new wave of innovators is stepping in—developing therapies that go beyond hormones and surgery. Subscribe: 𝗵𝘁𝘁𝗽𝘀://𝗮𝗿𝘁𝗲𝗺𝗶𝘀.𝗵𝗲𝗮𝗹𝘁𝗵/𝗰𝗼𝗻𝘁𝗮𝗰𝘁
🧠 𝘞𝘦 𝘥𝘰𝘯’𝘵 𝘫𝘶𝘴𝘵 𝘯𝘦𝘦𝘥 𝘣𝘦𝘵𝘵𝘦𝘳 𝘴𝘤𝘪𝘦𝘯𝘤𝘦—𝘸𝘦 𝘯𝘦𝘦𝘥 𝘢 𝘣𝘦𝘵𝘵𝘦𝘳 𝘴𝘺𝘴𝘵𝘦𝘮 𝘵𝘰 𝘣𝘳𝘪𝘯𝘨 𝘵𝘩𝘢𝘵 𝘴𝘤𝘪𝘦𝘯𝘤𝘦 𝘵𝘰 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴. artemis.health/white-paper-...
🧠 𝘞𝘦 𝘥𝘰𝘯’𝘵 𝘫𝘶𝘴𝘵 𝘯𝘦𝘦𝘥 𝘣𝘦𝘵𝘵𝘦𝘳 𝘴𝘤𝘪𝘦𝘯𝘤𝘦—𝘸𝘦 𝘯𝘦𝘦𝘥 𝘢 𝘣𝘦𝘵𝘵𝘦𝘳 𝘴𝘺𝘴𝘵𝘦𝘮 𝘵𝘰 𝘣𝘳𝘪𝘯𝘨 𝘵𝘩𝘢𝘵 𝘴𝘤𝘪𝘦𝘯𝘤𝘦 𝘵𝘰 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴. artemis.health/white-paper-...
Two healthcare executives speak about the state of affairs in Women’s Health and how companies can better address the needs of women worldwide.
Two healthcare executives speak about the state of affairs in Women’s Health and how companies can better address the needs of women worldwide.
On “How to Win Investors for Women’s Health”, with investment banker Kaitlin DeMarco of Locust Walk, venture capitalist Stasia Obremskey of Foreground Capital, and startup CEO Patric Stenberg of Gesynta Pharma.
On “How to Win Investors for Women’s Health”, with investment banker Kaitlin DeMarco of Locust Walk, venture capitalist Stasia Obremskey of Foreground Capital, and startup CEO Patric Stenberg of Gesynta Pharma.
Sweden-based Gesynta Pharma is a rising biotech company developing a new, non-hormonal therapy for endometriosis, currently in Phase 2 clinical trials.
Sweden-based Gesynta Pharma is a rising biotech company developing a new, non-hormonal therapy for endometriosis, currently in Phase 2 clinical trials.
Foreground Capital has a clear mission: to fuel innovation in Women’s Health - a space still underserved by most other investment funds.
Foreground Capital has a clear mission: to fuel innovation in Women’s Health - a space still underserved by most other investment funds.
Kaitlin DeMarco from Locust Walk sheds light on current trends in venture capital and how they impact the fundraising for Women’s Health startups.
Kaitlin DeMarco from Locust Walk sheds light on current trends in venture capital and how they impact the fundraising for Women’s Health startups.
Want to optimize your company’s partnering strategy?
Learn how successful licensing deals and powerful alliances drive innovation in Women’s Health and how they connect with startups early on.
Want to optimize your company’s partnering strategy?
Learn how successful licensing deals and powerful alliances drive innovation in Women’s Health and how they connect with startups early on.
💡Your expertise can drive the next 𝗯𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 in women’s health.
𝗝𝗼𝗶𝗻 𝗼𝘂𝗿 𝗻𝗲𝘁𝘄𝗼𝗿𝗸 𝘁𝗼𝗱𝗮y to connect, collaborate, and contribute to solutions that matter.
We engage in open, insightful dialogue that challenges conventional thinking. artemis.health/contact/
💡Your expertise can drive the next 𝗯𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 in women’s health.
𝗝𝗼𝗶𝗻 𝗼𝘂𝗿 𝗻𝗲𝘁𝘄𝗼𝗿𝗸 𝘁𝗼𝗱𝗮y to connect, collaborate, and contribute to solutions that matter.
We engage in open, insightful dialogue that challenges conventional thinking. artemis.health/contact/
You can be part of this artemis.health/contact/
You can be part of this artemis.health/contact/
In this webinar, meet two 𝗪𝗼𝗺𝗲𝗻'𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝗖𝗘𝗢𝘀 who raised a total of >$100m this year:
Dina Radenkovic of Gameto (fertility) and Scott Johnson of Comanche Biopharma (pre-eclampsia)
www.youtube.com/watch?v=SDUj...
In this webinar, meet two 𝗪𝗼𝗺𝗲𝗻'𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝗖𝗘𝗢𝘀 who raised a total of >$100m this year:
Dina Radenkovic of Gameto (fertility) and Scott Johnson of Comanche Biopharma (pre-eclampsia)
www.youtube.com/watch?v=SDUj...
Join Artemis' network to learn and connect. Gain visibility among industry and investors.
database.artemis.health/profile/create
Join Artemis' network to learn and connect. Gain visibility among industry and investors.
database.artemis.health/profile/create